PTC Therapeutics

PTC Therapeutics to Participate at Upcoming Investor Conferences

4 November 2024 -- New Jersey, US -- PTC Therapeutics, Inc today announced that the company will present a company overview at the following conferences: UBS Global Healthcare ConferenceWednesday, Nov. 13 at 2:45 p.m. PST / 5:45 p.m. EST Jefferies London Healthcare ConferenceTuesday, Nov. 19 at 11:30 a.m. GMT / 6:30 a.m. EST Citi's 2024...

PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients

1 October 2024 -- New Jersey, US -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the FDA has accepted for filing the New Drug Application (NDA) of sepiapterin for the treatment of pediatric and adult patients living with phenylketonuria (PKU). A Prescription Drug User Fee Act (PDUFA) target action date is expected to be provided in the...
PTC Therapeutics Inc. 100 Corporate Court South Plainfield, NJ 07080-2449

908 222 7000